Date & Time
June 14, 12:00 PM ET / 9:00 AM PT
Webinar Details provided upon RSVP Approval
About the Event
jCyte is developing a first-in-class cell therapy platform that holds the potential to restore vision in the millions of people worldwide with blinding retinal diseases.
Join our webinar with the jCyte leadership team to learn more about their recent Phase 2b clinical trial results and what the company’s FDA RMAT designation mean for the path forward.